ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 62 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,180 | -81.9% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $12,030 | +100.5% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | -33.3% | 1,000 | -50.0% | 0.00% | – |
| Q2 2022 | $9,000 | -47.1% | 2,000 | 0.0% | 0.00% | – |
| Q1 2022 | $17,000 | -41.4% | 2,000 | 0.0% | 0.00% | – |
| Q4 2021 | $29,000 | -47.3% | 2,000 | -20.0% | 0.00% | -100.0% |
| Q3 2021 | $55,000 | +175.0% | 2,500 | +66.7% | 0.00% | – |
| Q2 2021 | $20,000 | -100.0% | 1,500 | -98.8% | 0.00% | -100.0% |
| Q1 2021 | $1,249,680,000 | +20827900.0% | 123,000 | +8100.0% | 0.01% | – |
| Q4 2020 | $6,000 | +50.0% | 1,500 | +50.0% | 0.00% | – |
| Q2 2020 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -40.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | +66.7% | 1,000 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | +200.0% | 1,000 | +233.3% | 0.00% | – |
| Q3 2018 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | +100.0% | 300 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 576,317 | $1,504,000 | 1.50% |
| Phoenix Holdings Ltd. | 197,763 | $483,000 | 0.02% |
| Frontier Wealth Management LLC | 71,900 | $188,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 19,659 | $51,000 | 0.01% |
| Rossmore Private Capital | 15,061 | $39,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 98,486 | $255,000 | 0.01% |
| Virtu Financial LLC | 10,450 | $27,000 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $15,000 | 0.01% |
| Sterling Investment Advisors, Ltd. | 3,150 | $8,000 | 0.00% |
| Qube Research & Technologies Ltd | 75,395 | $197,000 | 0.00% |